The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Boytsov S.A.

National Research Centre for Preventive Medicine, Moscow, Russia

Shalnova S.A.

National Medical Research Center for Preventive Medicine, Moscow, Russia

Deev A.D.

"GNITs profilakticheskoĭ meditsiny" Minzdrava Rossii

Kalinina A.M.

National Research Center for Preventive Medicine, Ministry of Health of Russia, Moscow

Simulation of a risk for cardiovascular diseases and their events at individual and group levels

Authors:

Boytsov S.A., Shalnova S.A., Deev A.D., Kalinina A.M.

More about the authors

Journal: Therapeutic Archive. 2013;85(9): 4‑10

Read: 6131 times


To cite this article:

Boytsov SA, Shalnova SA, Deev AD, Kalinina AM. Simulation of a risk for cardiovascular diseases and their events at individual and group levels. Therapeutic Archive. 2013;85(9):4‑10. (In Russ.)

Recommended articles:
Prevalence and characteristics of risk factors for cere­brovascular disease in overweight. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):118-124
Epidemiology and prevention of prostate cancer. Russian Journal of Preventive Medi­cine. 2025;(7):111-118
Cere­bral venous thro­mbosis in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):11-19
Sex and age characteristics of stroke risk factors in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):89-97

References:

  1. Kannel W.B., Dawber T.R., Kagan A. et al. Factors of risk in the development of coronary heart disease - six year follow-up experience. The Framingham Study. Ann Intern Med 1961; 55: 33-50.
  2. Dawber T.R. Identification of excess cardiovascularrisk. A practical approach. Minn Med 1969; 52: 1217-1221.
  3. Wilson P.W., D'Agostino R.B., Levy D. et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
  4. Eichler K., Puhan M.A., Steurer J. et al. Prediction of first coronary events with the Framingham score: A systematic review. Am Heart J 2007; 153: 722-731.
  5. Jackson P.R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. Br Med J 2000; 320: 709-710.
  6. Anderson K.M., Wilson P.W., Odell P.M., Kannel W.B. An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83: 356-362.
  7. D'Agostino R.B. Sr., Grundy S., Sullivan L.M., Wilson P. CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001; 286: 180-187.
  8. Menotti A., Puddu P.E., Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000; 21: 365-370.
  9. Marrugat J., D'Agostino R., Sullivan L. et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Comm Health 2003; 57: 634-638.
  10. Hense H.W., Schulte H., Lowel H. et al. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany - results from MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003; 3: 1-9.
  11. Thomsen T.F., McGee D., Davidsen M., Jorgensen T. A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol 2002; 31: 817-822.
  12. Brindle P., Emberson J., Lampe F. et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. Br Mtd J 2003; 327: 1267-1270.
  13. Conroy R.M., Pyorala K., Fitzgerald A.P. et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
  14. Ramsay S.E., Morris R.W., Whincup P.H. et al. Prediction of coronary heart disease risk by Framingham and SCORE risk assessments varies by socioeconomic position: results from a study in British men. Eur J Cardiovasc Prev Rehabil 2011; 18 (2): 186-193.
  15. ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J 2011; 32 (14): 1769-1818.
  16. Ridker P.M., Buring J.E., Rifai N., Cook N.R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007; 297: 611-619.
  17. Ridker P.M., Paynter N.P., Rifai N. et al. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 2008; 118: 2243-2251.
  18. Pencina M.J., D'Agostino R.B., Larson M.G. et al. Predicting the 30-year risk of cardiovascular disease. The Framingham Study. Circulation 2009; 119: 3078-3084.
  19. DeFilippis A.P., Blaha M.J., Ndumele C.E. et al. The Association of Framingham and Reynolds Risk Scores With Incidence and Progression of Coronary Artery Calcification in MESA (Multi-Ethnic Study of Atherosclerosis). JACC 2011; 58 (20): 2076-2083.
  20. Schnabel R.B., Sullivan L.M., Levy D. et al. Development of a Risk Score for Atrial Fibrillation in the Community; The Framingham Heart Study Lancet 2009; 373 (9665): 739-745.
  21. Pletcher M.J., Tice J.A., Pignone M., Browner W.S. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med 2004; 164 (12): 1285-1292.
  22. Greenland P., LaBree L., Azen S.P. et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004; 291: 210-215.
  23. Detrano R.C., Wong N.D., Doherty T.M. et al. Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation 1999; 99 (20): 2633-2638.
  24. Assmann G., Cullen P., Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 2002; 105: 310-315.
  25. Assmann G., Schulte H., Cullen P., Seedorf U. Assessing risk of myocardial infarction and stroke; new data from the Prospective Cardiovascular Muenster (PROCAM) Study. Eur J Clin Invest 2007; 37: 925-932.
  26. Thomsen T.F., Davidsen M., Ibsen H. et al. A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score. J Cardiovasc Risk 2001; 8 (5): 291-297.
  27. Janssen I., Katzmarzyk P.T., Church T.S., Blair S.N. The Cooper Clinic Mortality Risk Index: clinical score sheet for men. Am J Prev Med 2005; 29 (3): 194-203.
  28. Shal'nova S.A., Oganov R.G., Deev A.D. Otsenka i upravlenie riskom serdechno-sosudistykh zabolevanii dlya naseleniya Rossii. Kardiovask ter i prof 2004; 4: 4-11.
  29. Tsarev O.A., Prokin F.G. Avtomatizirovannaya sistema dlya neinvazivnogo monitoringa stepeni kardiovaskulyarnogo riska http://mtp.sgmu.ru/projects/048.pdf
  30. Vorob'eva E.N., Usolkin K.M., Mukh E.A. i dr. Avtomatizirovannoe prognozirovanie infarkta miokarda i insul'ta. Uspekhi sovr estestvozn 2005; 4: 48-49.
  31. Chepurina H.A., Shal'nova S.A., Deev A.D. Prognosticheskaya znachimost' summarnogo riska serdechno-sosudistykh zabolevanii i faktorov, ego opredelyayushchikh: 10-letnee nablyudenie vyborki muzhchin - gosudarstvennykh sluzhashchikh. Kardiol i serd-sosud khir 2009; 1:15-20
  32. Shal'nova S.A., Kalinina A.M., Deev A.D., Pustelenin A.V. Rossiiskaya ekspertnaya sistema Otsenki RISKa Osnovnykh Neinfektsionnykh zabolevanii (ORISKON). Kardiovask ter i prof 2013; 4. Prinyato v pechat'.
  33. Kalinina A.M. Nauchnye dokazatel'nye fakty profilaktiki serdechno-sosudistykh zabolevanii v prakticheskom zdravookhranenii (k 35-letiyu ot nachala issledovaniya "Mnogofaktornaya profilaktika ishemicheskoi bolezni serdtsa sredi neorganizovannogo naseleniya") 35 let - 35 urokov. Kardiovask ter i prof 2010; 1: 14-20.
  34. Kalinina A.M., Kontsevaya A.V., Deev A.D. Dolgosrochnaya ekonomicheskaya effektivnost' programmy mnogofaktornoi profilaktiki serdechno-sosudistykh zabolevanii v pervichnoi mediko-sanitarnoi pomoshchi. Kardiovask ter i prof 2013; 1: 60-66.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.